Literature DB >> 19357181

Podocyte-specific expression of organic cation transporter PMAT: implication in puromycin aminonucleoside nephrotoxicity.

Li Xia1, Mingyan Zhou, Thomas F Kalhorn, Horace T B Ho, Joanne Wang.   

Abstract

Plasma membrane monoamine transporter (PMAT) is a novel polyspecific organic cation transporter that transports organic cations and the purine nucleoside, adenosine. PMAT is expressed in the kidney, but the specific localization and function of this transporter in renal cells are unclear. In this study, we developed a polyclonal antibody toward a 14-amino acid sequence in the last intracellular loop of PMAT and determined the precise cellular localization of PMAT in human and rat kidneys. Surprisingly, we found that the PMAT protein was predominantly expressed in the glomerulus with minimal expression in tubular cells. Within the glomerulus, dual-color immunofluorescence labeling showed that the PMAT protein was specifically localized to the visceral glomerular epithelial cells, i.e., podocytes. There was no significant PMAT immunoreactivity in mesangial or glomerular endothelial cells. We further showed that puromycin aminonucleoside (PAN), a classic podocyte toxin that induces massive proteinuria and severe glomerulopathy, is transported by PMAT. Expression of PMAT in Madin-Darby canine kidney cells significantly increased cell sensitivity to PAN. Decynium 22, a potent PMAT inhibitor, abolished PAN toxicity in PMAT-expressing cells. Together, our data suggest that PMAT is specifically expressed in podocytes and may play an important role in PAN-induced kidney injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19357181      PMCID: PMC2692440          DOI: 10.1152/ajprenal.00046.2009

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  31 in total

Review 1.  Mechanisms and clinical implications of renal drug excretion.

Authors:  R Masereeuw; F G Russel
Journal:  Drug Metab Rev       Date:  2001 Aug-Nov       Impact factor: 4.518

Review 2.  Biology of the human podocyte.

Authors:  Moin A Saleem
Journal:  Nephron Exp Nephrol       Date:  2003

Review 3.  Causes and consequences of proteinuria: the kidney filtration barrier and progressive renal failure.

Authors:  K Tryggvason; E Pettersson
Journal:  J Intern Med       Date:  2003-09       Impact factor: 8.989

Review 4.  Molecular and cellular physiology of renal organic cation and anion transport.

Authors:  Stephen H Wright; William H Dantzler
Journal:  Physiol Rev       Date:  2004-07       Impact factor: 37.312

5.  Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1.

Authors:  Edmund S Ho; Deborah C Lin; Dirk B Mendel; Tomas Cihlar
Journal:  J Am Soc Nephrol       Date:  2000-03       Impact factor: 10.121

Review 6.  Wilms tumor and the WT1 gene.

Authors:  S B Lee; D A Haber
Journal:  Exp Cell Res       Date:  2001-03-10       Impact factor: 3.905

Review 7.  Transcriptional regulation of podocyte specification and differentiation.

Authors:  Susan E Quaggin
Journal:  Microsc Res Tech       Date:  2002-05-15       Impact factor: 2.769

Review 8.  Inducible rodent models of acquired podocyte diseases.

Authors:  Jeffrey W Pippin; Paul T Brinkkoetter; Fionnualla C Cormack-Aboud; Raghu V Durvasula; Peter V Hauser; Jolanta Kowalewska; Ronald D Krofft; Christine M Logar; Caroline B Marshall; Takamoto Ohse; Stuart J Shankland
Journal:  Am J Physiol Renal Physiol       Date:  2008-09-10

Review 9.  The SLC22 drug transporter family.

Authors:  Hermann Koepsell; Hitoshi Endou
Journal:  Pflugers Arch       Date:  2003-07-19       Impact factor: 3.657

Review 10.  Mammalian nucleoside transporters.

Authors:  Wei Kong; Karen Engel; Joanne Wang
Journal:  Curr Drug Metab       Date:  2004-02       Impact factor: 3.731

View more
  18 in total

1.  Electrophysiological characterization of the polyspecific organic cation transporter plasma membrane monoamine transporter.

Authors:  Shiro Itagaki; Vadivel Ganapathy; Horace T B Ho; Mingyan Zhou; Ellappan Babu; Joanne Wang
Journal:  Drug Metab Dispos       Date:  2012-03-06       Impact factor: 3.922

2.  Molecular analysis and structure-activity relationship modeling of the substrate/inhibitor interaction site of plasma membrane monoamine transporter.

Authors:  Horace T B Ho; Yongmei Pan; Zhiyi Cui; Haichuan Duan; Peter W Swaan; Joanne Wang
Journal:  J Pharmacol Exp Ther       Date:  2011-08-04       Impact factor: 4.030

Review 3.  Advances in predictive in vitro models of drug-induced nephrotoxicity.

Authors:  Joanne Y-C Soo; Jitske Jansen; Rosalinde Masereeuw; Melissa H Little
Journal:  Nat Rev Nephrol       Date:  2018-06       Impact factor: 28.314

4.  Tyrosine 112 is essential for organic cation transport by the plasma membrane monoamine transporter.

Authors:  Horace T B Ho; Joanne Wang
Journal:  Biochemistry       Date:  2010-09-14       Impact factor: 3.162

5.  Effect of phospholipidosis on the cellular pharmacokinetics of chloroquine.

Authors:  Nan Zheng; Xinyuan Zhang; Gus R Rosania
Journal:  J Pharmacol Exp Ther       Date:  2010-12-14       Impact factor: 4.030

6.  The contribution of low-affinity transport mechanisms to serotonin clearance in synaptosomes.

Authors:  Catherine E Hagan; James O Schenk; John F Neumaier
Journal:  Synapse       Date:  2011-04-07       Impact factor: 2.562

7.  Impaired monoamine and organic cation uptake in choroid plexus in mice with targeted disruption of the plasma membrane monoamine transporter (Slc29a4) gene.

Authors:  Haichuan Duan; Joanne Wang
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

8.  Over-expression of adenosine deaminase in mouse podocytes does not reverse puromycin aminonucleoside resistance.

Authors:  Gaëlle Brideau; Alain Doucet
Journal:  BMC Nephrol       Date:  2010-07-22       Impact factor: 2.388

Review 9.  The plasma membrane monoamine transporter (PMAT): Structure, function, and role in organic cation disposition.

Authors:  J Wang
Journal:  Clin Pharmacol Ther       Date:  2016-09-19       Impact factor: 6.875

10.  Residue Ile89 in human plasma membrane monoamine transporter influences its organic cation transport activity and sensitivity to inhibition by dilazep.

Authors:  Horace T B Ho; Li Xia; Joanne Wang
Journal:  Biochem Pharmacol       Date:  2012-05-04       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.